AXSM
Axsome Therapeutics, Inc.
Stock
$179.25−2.82 (−1.55%)Close Oct 2, 2026
- Operating cash flow, 2025
- −$93M
Operating cash flow
Operating cash flow by fiscal year
| Period | Operating cash flow | YoY |
|---|---|---|
| 2025 | −$93M | — |
| 2024 | −$128M | — |
| 2023 | −$145M | — |
| 2022 | −$117M | — |
| 2021 | −$108M | — |
| 2020 | −$78M | — |
| 2019 | −$46M | — |
| 2018 | −$30M | — |
| 2017 | −$26M | — |
| 2016 | −$21M | — |
| 2015 | −$7.4M | — |
| 2014 | −$4.6M | — |